Back to search

Article

A benzoxazolylurea inhibits VraS and enhances antimicrobials against vancomycin intermediate-resistant <i>Staphylococcus aureus</i>

2023-09-03

Abstract excerpt

<h4>ABSTRACT</h4> Vancomycin intermediate-resistant Staphylococcus aureus (VISA) is a pathogen of concern. VraS, a histidine kinase, facilitates the VISA phenotype. Here, we reveal a benzoxazolylurea that directly inhibits VraS and enhances vancomycin to below the clinical breakpoint against an archetypal VISA strain. To the best of our knowledge, this is the first direct VraS inhibitor ever reported that shows s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1718c8e1-787f-5d02-8c50-68b0bb970abd
DOI
10.1101/2023.08.31.555806
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A benzoxazolylurea inhibits VraS and enhances antimicrobials against vancomycin intermediate-resistant <i>Staphylococcus aureus</i>DOI 10.1101/2023.08.31.555806
Select a neighboring publication to make it the new centre.